ROMEO, MARIO
 Distribuzione geografica
Continente #
EU - Europa 3.550
AS - Asia 1.481
NA - Nord America 1.171
SA - Sud America 224
AF - Africa 28
OC - Oceania 2
Totale 6.456
Nazione #
RU - Federazione Russa 2.738
US - Stati Uniti d'America 1.126
SG - Singapore 488
IT - Italia 382
CN - Cina 354
VN - Vietnam 214
BR - Brasile 180
IE - Irlanda 174
HK - Hong Kong 171
KR - Corea 81
DE - Germania 73
JP - Giappone 60
IN - India 47
FR - Francia 39
GB - Regno Unito 31
NL - Olanda 27
AR - Argentina 22
AT - Austria 20
CA - Canada 20
MX - Messico 16
FI - Finlandia 15
BD - Bangladesh 13
ZA - Sudafrica 10
ID - Indonesia 9
EC - Ecuador 8
IQ - Iraq 8
PK - Pakistan 7
EG - Egitto 6
ES - Italia 6
GR - Grecia 6
PL - Polonia 6
TR - Turchia 6
CO - Colombia 5
SE - Svezia 5
CZ - Repubblica Ceca 4
UA - Ucraina 4
UZ - Uzbekistan 4
BE - Belgio 3
KE - Kenya 3
LT - Lituania 3
MA - Marocco 3
MY - Malesia 3
PE - Perù 3
VE - Venezuela 3
AU - Australia 2
AZ - Azerbaigian 2
BG - Bulgaria 2
BO - Bolivia 2
DO - Repubblica Dominicana 2
DZ - Algeria 2
HN - Honduras 2
IR - Iran 2
JM - Giamaica 2
KG - Kirghizistan 2
MK - Macedonia 2
PT - Portogallo 2
AE - Emirati Arabi Uniti 1
AM - Armenia 1
AO - Angola 1
BA - Bosnia-Erzegovina 1
CH - Svizzera 1
CL - Cile 1
CR - Costa Rica 1
DK - Danimarca 1
ET - Etiopia 1
HR - Croazia 1
IM - Isola di Man 1
JO - Giordania 1
KZ - Kazakistan 1
LK - Sri Lanka 1
LV - Lettonia 1
LY - Libia 1
MM - Myanmar 1
MO - Macao, regione amministrativa speciale della Cina 1
NO - Norvegia 1
PA - Panama 1
SA - Arabia Saudita 1
SK - Slovacchia (Repubblica Slovacca) 1
SV - El Salvador 1
SY - Repubblica araba siriana 1
TG - Togo 1
TH - Thailandia 1
Totale 6.456
Città #
Moscow 962
Singapore 253
San Jose 237
Dublin 172
Hong Kong 166
Santa Clara 136
Ashburn 127
Naples 119
Hefei 90
Ho Chi Minh City 82
Seoul 81
Chandler 59
Beijing 58
New York 50
Hanoi 47
Dallas 39
Bengaluru 29
Los Angeles 25
Boardman 24
Munich 21
Rome 18
São Paulo 18
Amsterdam 17
Paris 16
Da Nang 15
Orem 15
Boydton 13
Bremen 13
Nuremberg 13
Vienna 13
Princeton 11
Caserta 10
Roxbury 10
Viterbo 10
Cambridge 9
Haiphong 9
Milan 9
Salerno 9
The Dalles 9
Tokyo 9
Chennai 8
Frankfurt am Main 8
Mexico City 8
Atlanta 7
Aversa 7
Council Bluffs 7
Falkenstein 7
Memphis 7
Montreal 7
Belo Horizonte 6
Fondi 6
Sennori 6
Turku 6
Brasília 5
Buffalo 5
Curitiba 5
Des Moines 5
Helsinki 5
Hillsboro 5
Manassas 5
Ninh Bình 5
Pavia 5
Warsaw 5
Baghdad 4
Biên Hòa 4
Brooklyn 4
Cairo 4
Cesa 4
Chicago 4
Hải Dương 4
Jacksonville 4
Johannesburg 4
Lappeenranta 4
London 4
Phoenix 4
San Francisco 4
Sialkot 4
Tashkent 4
Tianjin 4
Toronto 4
Vũng Tàu 4
Bari 3
Bisaccia 3
Brussels 3
City of London 3
Guayaquil 3
Hangzhou 3
Juneau 3
Lima 3
Manchester 3
Medford 3
Mumbai 3
Nairobi 3
Padova 3
Porto Alegre 3
Pune 3
Quito 3
Rio de Janeiro 3
Stockholm 3
Thái Nguyên 3
Totale 3.292
Nome #
Adherence and Effects Derived from FODMAP Diet on Irritable Bowel Syndrome: A Real Life Evaluation of a Large Follow-Up Observation 180
A 60-Year-Old Woman with Primary Biliary Cholangitis and Crohn's Ileitis Following the Suspension of Ursodeoxycholic Acid 177
Just Drink a Glass of Water? Effects of Bicarbonate-Sulfate-Calcium-Magnesium Water on the Gut-Liver Axis 169
A holistic evaluation of patients with chronic Hepatitis D virus (HDV) infection enrolled in the Italian PITER-B and delta cohort 166
May chronic cough in chronic obstructive pulmonary disease be a contraindication of Percutaneous Endoscopic Gastrostomy placement: a case report 161
Alcoholic Consumption of Young Italians During the SARS-CoV-2 Pandemic 156
The bisphenol a induced oxidative stress in non-alcoholic fatty liver disease male patients: A clinical strategy to antagonize the progression of the disease 145
The use of bicarbonate-sulphate-calcium-magnesium and sodium-low drinkable water improves functional gastrointestinal symptoms in patients with non-alcoholic fatty liver disease: A prospective study 143
The urotensin-II receptor: A marker for staging and steroid outcome prediction in ulcerative colitis 143
Chemical effect of bisphenol a on non-alcoholic fatty liver disease 141
INTESTINAL MICROBIOTA, INTESTINAL PERMEABILITY AND THE UROGENITAL TRACT: IS THERE A PATHOPHYSIOLOGICAL LINK? 139
The Lesson from the First Italian Lockdown: Impacts on Anxiety and Depressive Symptoms and Sleep Quality in Patients with Remission of Inflammatory Bowel Disease 137
Red cell distribution width/platelet ratio estimates the 3-year risk of decompensation in Metabolic Dysfunction-Associated Steatotic Liver Disease-induced cirrhosis 136
Risk of multiple sclerosis relapses when switching from fingolimod to cell-depleting agents: the role of washout duration 135
The JAK-STAT Pathway as a Therapeutic Strategy in Cancer Patients with Immune Checkpoint Inhibitor-Induced Colitis: A Narrative Review 134
The Melanocortin System in Inflammatory Bowel Diseases: Insights into Its Mechanisms and Therapeutic Potentials 132
Dysgeusia in MASLD-related advanced chronic liver disease (ACLD): a silent driver towards the "Bermuda" triangle of malnutrition-sarcopenia-frailty severely affecting prognosis 130
Are insulin resistance and non-alcoholic fatty liver disease associated with Peyronie's disease? A pilot study 129
Systemic Oxidative Balance Reflects the Liver Disease Progression Status for Primary Biliary Cholangitis (Pbc): The Narcissus Fountain 126
Role of Non-Coding RNAs in Hepatocellular Carcinoma Progression: From Classic to Novel Clinicopathogenetic Implications 126
Intestinal pseudo-obstruction as systemic lupus erythematosus complication: is it time to reconsider the role of surgery? A case report of a tailored multidisciplinary managed 44-year-old male patient 125
FLAME: Training and Validating a Newly Conceived Model Incorporating Alpha-Glutathione-S-Transferase Serum Levels for Predicting Advanced Hepatic Fibrosis and Acute Cardiovascular Events in Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) 124
Environmental bisphenol A exposure triggers trained immunity-related pathways in monocytes 124
The Burden of Irritable Bowel Syndrome in Medical and Nurse Italian University Student Population: The VANVITELLI-IBS Survey 123
Exploring the Epidemiologic Burden, Pathogenetic Features, and Clinical Outcomes of Primary Liver Cancer in Patients with Type 2 Diabetes Mellitus (T2DM) and Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD): A Scoping Review 120
Exploring the Classic and Novel Pathogenetic Insights of Plastic Exposure in the Genesis and Progression of Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) 120
The analysis of alcohol consumption during the severe acute respiratory syndrome coronavirus 2 Italian lockdown 114
Quality of bowel preparation in patients with inflammatory bowel disease undergoing colonoscopy: What factors to consider? 112
Systemic Oxidative Stress Correlates with Sarcopenia and Pruritus Severity in Primary Biliary Cholangitis (PBC): Two Independent Relationships Simultaneously Impacting the Quality of Life—Is the Low Absorption of Cholestasis-Promoted Vitamin D a Puzzle Piece? 111
Clinical Applications of Artificial Intelligence (AI) in Human Cancer: Is It Time to Update the Diagnostic and Predictive Models in Managing Hepatocellular Carcinoma (HCC)? 110
Nutritional and Psychological Support as a Multidisciplinary Coordinated Approach in the Management of Chronic Liver Disease: A Scoping Review 109
Nutrigenomics and nutrigenetics in metabolic-(Dysfunction) associated fatty liver disease: Novel insights and future perspectives 107
Spleen Area Affects the Performance of the Platelet Count–Based Non-invasive Tools in Predicting First Hepatic Decompensation in Metabolic Dysfunction–Associated Steatotic Liver Disease Cirrhosis 106
Inflammatory bowel diseases patients suffer from significant low levels and barriers to physical activity: The "BE-FIT-IBD" study 106
Immunity as cornerstone of non-alcoholic fatty liver disease: The contribution of oxidative stress in the disease progression 105
PNPLA3, TM6SF2, and MBOAT7 Influence on Nutraceutical Therapy Response for Non-alcoholic Fatty Liver Disease: A Randomized Controlled Trial 105
Vanek's Tumour as a Rare Cause of Dyspeptic Syndrome in a Patient with Primary Biliary Cholangitis: A Case Report 101
From “Traditional” to “Trained” Immunity: Exploring the Novel Frontiers of Immunopathogenesis in the Progression of Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) 100
Telemedicine in inflammatory bowel diseases: A new brick in the medicine of the future? 99
Prediction of Clinical Trajectory in HCV-Related ACLD after SVR: Role of Liver Stiffness in a 5-Years Prospective Study 99
The influence of acute lifestyle changes on NAFLD evolution in a multicentre cohort: a matter of body composition 98
The Role of the Gut–Biliary–Liver Axis in Primary Hepatobiliary Liver Cancers: From Molecular Insights to Clinical Applications 98
The Role of Insulin Resistance in Fueling NAFLD Pathogenesis: From Molecular Mechanisms to Clinical Implications 97
Urinary volatile Organic compounds in non-alcoholic fatty liver disease (NAFLD), type two diabetes mellitus (T2DM) and NAFLD-T2DM coexistence 96
Letter: Different Risk of Acute Variceal Bleeding According to the Liver Disease Aetiology in Decompensated Cirrhosis Patients Receiving Carvedilol‐Based Primary Prophylaxis—May Insulin Resistance Unloose This Gordian Knot? 96
Is it time to reconsider the MRP6 role in bile secretion and LPAC genetic signature? 94
Myosteatosis is closely associated with sarcopenia and significantly worse outcomes in patients with cirrhosis 91
The role of fructose in non-alcoholic steatohepatitis: Old relationship and new insights 91
Primary biliary cholangitis, Celiac Disease, and MASLD: the triumvirate of steatosis. How should we manage this triple overlap? 89
Beneficial Effects of Long-Lasting Bicarbonate–Sulfate–Calcium–Magnesium Water Intake on Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD)-Related Outcomes via Impacting Intestinal Permeability (IP), IP-Related Systemic Inflammation, and Oxidative Stress 87
Phase Angle/C-reactive Protein-Index as a Novel Combined Tool for Predicting Liver-Related Hospitalizations in MASLD-Decompensated Cirrhosis 87
Reduction of the Risk of Hepatocellular Carcinoma over Time Using Direct-Acting Antivirals: A Propensity Score Analysis of a Real-Life Cohort (PITER HCV) 83
Managing Ascites and Kidney Dysfunction in Decompensated Advanced Chronic Liver Disease: From “One Size Fits All” to a Multidisciplinary-Tailored Approach 79
The Medical Impact of Hepatitis D Virus Infection in Natives and Immigrants: The Italian Paradigm 78
Pneumococcal vaccination status among cirrhotic patients in Italy: a neglected topic 73
The Personalized Management of Primary Biliary Cholangitis in the Era of Precision Medicine: Current Challenges and Future Perspectives 26
From “MAFLD” to “MASLD”: Was This Revolution Worth It? A Head-to-Head Comparison of MAFLD and MASLD Criteria in Estimating Liver Disease Progression and Cardiovascular Risk in Real Life 26
Human Albumin-enriched Peritoneal Dialysis: A Novel Approach to Manage Refractory Ascites and Kidney Dysfunction in Decompensated Advanced Chronic Liver Disease 17
Risk Factors for Inadequate Bowel Preparation Before Colonoscopy in Patients with Ulcerative Colitis in Clinical and Endoscopic Remission: A Multicenter Retrospective Cohort Study 10
Beyond Insulin Resistance: Exploring the Centrality of the Gut–Liver Axis in Mediating Immunometabolic Dysregulation Driving Hepatocellular Carcinoma in MASLD and Diabetes 5
Contrast-enhanced ultrasound as a problem-solving tool and irreversible electroporation for a perivascular/peribiliary segment IVs colorectal liver metastasis: a case report 1
Redefining Liver Transplantation Indications for Hepatic Malignancies in the Era of Precision Transplant Oncology: An Up-to-Date Narrative Review 1
Totale 6.548
Categoria #
all - tutte 20.174
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 20.174


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20215 0 0 0 0 0 0 0 0 0 0 0 5
2021/2022110 0 6 6 14 15 9 1 0 5 4 27 23
2022/2023348 17 9 6 20 75 17 2 14 156 9 13 10
2023/2024323 19 11 24 29 55 58 9 9 5 10 31 63
2024/2025804 22 16 16 38 119 92 105 91 95 65 81 64
2025/20264.894 209 346 264 183 420 2.565 236 219 156 118 101 77
Totale 6.548